References
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
- Jick H, Derby L E, Myers M W, Vasilakis C, Newton K M. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogen. Lancet 1996; 348: 981–983
- Sturdee D W, MacLennan A H. Reducing the problems of the progestogen. Climacteric 2006; 9: 241–243
- Harman S M, Brinton E A, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric 2005; 8: 3–12
- Lindsay R, Gallagher J C, Kleerekoper M, et al. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women. JAMA 2002; 287: 2668–2676
- Pickar J H, Yeh I T, Wheeler J E, Cunnane M F, Speroff L. Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results. Fertil Steril 2003; 80: 1234–1240
- Panay N, Ylikorkala O, Archer D F, et al. Ultra-low-dose estradiol and norethisterone acetate: effective menopause symptom relief. Climacteric 2007; 10: 120–131
- Lundström E, Bygdeson M, Svane G, Azavedo E, von Schoultz B. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density. Climacteric 2007; 10: 249–256
- Sturdee D W, Archer D F, Rakov V, Lang E. CHOICE Study Investigators. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women. Climacteric 2008; 11: 63–73
- Greenwald M W, Gluck O S, Lang E, Rakov V. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects. Menopause 2005; 12: 741–748
- Ettinger B, Kristine E, Ensrud E, et al. Effects of ultra low-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 2004; 104: 443–451
- Gambacciani M, Genazzani A R. Hormone replacement therapy: the benefits in tailoring the regimen and dose. Maturitas 2001; 40: 195–201